Catalyst Pharmaceuticals
People living with rare and difficult-to-treat conditions can’t wait, so we act with urgency, embracing every opportunity to create solutions that help improve someone’s quality of life. That goes beyond developing and commercializing groundbreaking medicines. We partner closely with advocacy groups to enable patients and caregivers, allowing them to make informed decisions that lead to better health outcomes.
Basic Information
- Category: Rare Diseases
- Founded: 2002
- Headquarters: Coral Gables, FL
- Website: catalystpharma.com
Documented Facts
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: CPRX (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Catalyst Pharmaceuticals — Official Site (official)
- Catalyst Pharmaceuticals on instagram (social)
- Catalyst Pharmaceuticals on facebook (social)
- CATALYST PHARMACEUTICALS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Rare Diseases profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Catalyst Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/catalyst-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/catalyst-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/catalyst-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:07.605Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
People living with rare and difficult-to-treat conditions can’t wait, so we act with urgency, embracing every opportunity to create solutions that help improve someone’s quality of life. That goes beyond developing and commercializing groundbreaking medicines. We partner closely with advocacy groups to enable patients and caregivers, allowing them to make informed decisions that lead to better health outcomes.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.